80 studies found for:    rivastigmine
Show Display Options
Rank Status Study
21 Recruiting Rivastigmine Patch in Veterans With Cognitive Impairment Following TBI
Conditions: Traumatic Brain Injury;   Cognitive Impairment
Intervention: Drug: Rivastigmine Transdermal Patch
22 Completed
Has Results
Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Rivastigmine transdermal patch;   Drug: Placebo
23 Completed Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine, memantine
24 Terminated
Has Results
Rivastigmine in Multiple Sclerosis Patients With Cognitive Impairment
Conditions: Multiple Sclerosis;   Cognitive Impairment
Interventions: Drug: Rivastigmine transdermal patch;   Drug: Placebo
25 Completed
Has Results
The Effects of the Rivastigmine Patch on Parkinson's Disease With Memory and/or Thinking Problems
Conditions: Parkinsons Disease With Dementia;   Parkinsons Disease With Mild to Moderate Memory and/or Thinking Problems
Intervention: Drug: Rivastigmine Patch 9.5 cm2
26 Terminated Methylphenidate, Rivastigmine or Haloperidol in Hypoactive Delirium in Intensive Care Patients
Condition: Delirium
Interventions: Drug: Haloperidol;   Drug: Methylphenidate;   Drug: Rivastigmine;   Other: No intervention
27 Unknown  Mild Cognitive Impairment in Parkinson's Disease
Conditions: Parkinson's Disease;   Mild Cognitive Impairment
Interventions: Drug: Exelon Patch (rivastigmine transdermal system);   Drug: Placebo Patches
28 Completed Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury and Cognitive Impairment
Condition: Traumatic Brain Injury
Intervention: Drug: Rivastigmine
29 Completed Rivastigmine Capsules in Patients With Probable Vascular Dementia
Condition: Vascular Dementia
Intervention: Drug: Rivastigmine
30 Completed A 12 Week, Multicenter, Open Label Evaluation of Caregiver Preference, Safety and Tolerability of Exelon® Patch (Rivastigmine Transdermal) in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine transdermal
31 Completed Efficacy of Rivastigmine in Patients With Down Syndrome
Condition: Down Syndrome
Intervention: Drug: Rivastigmine
32 Completed Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine transdermal patch
33 Unknown  Cognitive Changes in Alzheimer's Disease Patients Associated With or Without White Matter Changes After Rivastigmine
Condition: Alzheimer's Disease
Intervention: Drug: rivastigmine patch
34 Completed Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine, memantine
35 Unknown  Efficacy Study for Treatment of Dementia in Progressive Supranuclear Palsy
Conditions: Progressive Supranuclear Palsy;   Dementia
Intervention: Drug: rivastigmine
36 Terminated Rivastigmine for Intensive Care Unit (ICU) Delirium
Condition: Delirium
Interventions: Drug: Rivastigmine;   Drug: Placebo
37 Completed Study of Rivastigmine to Treat Parkinsonian Apathy Without Dementia
Conditions: Parkinson's Disease;   Apathy;   no Dementia
Interventions: Drug: rivastigmine;   Drug: placebo
38 Terminated Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment
Condition: Cognitive Symptoms
Intervention: Drug: Rivastigmine
39 Completed Randomized, Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20)
Condition: Alzheimer's Disease
Interventions: Drug: Active Comparator;   Drug: ENA713
40 Completed An Extension Study Evaluating the Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury (TBI) With Persistent Cognitive Deficits
Condition: Traumatic Brain Injury With Persistent Cognitive Deficits
Intervention: Drug: Rivastigmine

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years